focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.20
Bid: 140.90
Ask: 147.00
Change: -1.40 (-0.98%)
Spread: 6.10 (4.329%)
Open: 141.70
High: 143.00
Low: 138.60
Prev. Close: 142.60
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Jan 2016 16:26

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii Amlin plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached x
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to thenotification obligation: iii Morgan Stanley

(Institutional Securities Group and Global Wealth Management)

4. Full name of shareholder(s)(if different from 3.):iv
5. Date of the transaction and date onwhich the threshold is crossed orreached: v 31/12/2015
6. Date on which issuer notified: 05/01/2016
7. Threshold(s) that is/are crossed orreached: vi, vii 5%*
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction Resulting situation after the triggering transaction
NumberofShares NumberofVotingRights Numberof shares Number of votingrights % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
184,059 184,059 5,395,300 5,395,300 1.07%
GB00B2988H17
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financialinstrument Expirationdate xiii Exercise/ Conversion Period xiv Number of votingrights that may beacquired if theinstrument isexercised/ converted. % of votingrights
Right of Recall over a securities lending agreement N/A N/A

24,144,911

4.80%
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financialinstrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx

Equity Swap (Cash Settled)

N/A 11-11-2016 N/A 150,000 Nominal Delta
N/A 0.03%
Total (A+B+C)
Number of voting rights Percentage of voting rights

29,690,211

5.90%
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA is a direct holder of 29,690,211 voting rights (5.90%) and is a subsidiary of Morgan Stanley Investments (UK)

Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder of 29,690,211 voting rights (5.90%) and is a subsidiary of Morgan Stanley UK Group

Morgan Stanley UK Group, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of

29,690,211 voting rights (5.90%) and is a subsidiary of Morgan Stanley International Limited.

Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 29,690,211 voting rights (5.90%) and is a subsidiary of Morgan Stanley International Holdings Inc.

Morgan Stanley International Holdings Inc., c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware DE 19801, USA is an indirect holder of

29,690,211 voting rights (5.90%) and is a subsidiary of Morgan Stanley.

Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will ceaseto hold: N/A
12. Date on which proxy holder will cease to holdvoting rights: N/A
13. Additional information:

Amlin plc

14. Contact name: Mark Stevens, Company Secretary
15. Contact telephone number: 020 7746 1000

View source version on businesswire.com: http://www.businesswire.com/news/home/20160105006298/en/

Copyright Business Wire 2016

Date   Source Headline
28th Sep 20227:00 amRNSResults of Rights Issue and Total Voting Rights
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20224:35 pmRNSPrice Monitoring Extension
14th Sep 20224:38 pmRNSHolding(s) in Company
14th Sep 20229:49 amRNSHolding(s) in Company
14th Sep 20229:46 amRNSHolding(s) in Company
14th Sep 20227:00 amRNSRights Issue offer period amended
13th Sep 20229:00 amRNSHolding(s) in Company
12th Sep 20227:00 amRNSAdmission of Nil Paid Rights
9th Sep 20227:00 amRNSAdmission of placing shares & total voting rights
8th Sep 202211:32 amRNSResult of General Meeting
5th Sep 202212:28 pmRNSPublication of Prospectus
5th Sep 20227:00 amRNS4 for 1 c.£575.8 million Rights Issue
22nd Aug 20227:00 amRNSCircular and Notice of General Meeting
29th Jul 20227:00 amRNSHalf-year Report
15th Jul 20227:00 amRNSProposed New Equity Financing and Investment
1st Jul 20223:37 pmRNSHolding(s) in Company
1st Jul 202211:38 amRNSHolding(s) in Company
30th Jun 20223:31 pmRNSStatement Regarding Media Commentary
20th Jun 20221:20 pmRNSCompany Secretary Change
14th Jun 20227:00 amRNSDirector/PDMR Shareholding
25th May 202212:04 pmRNSResult of AGM
11th May 20227:00 amRNSHolding(s) in Company
4th May 20227:01 amRNS1st Quarter Results
4th May 20227:00 amRNSAppointment of New Chief Executive Officer
3rd May 20227:00 amRNSNew Chief Financial Officer Joins Board
28th Apr 20223:14 pmRNSHolding(s) in Company
25th Apr 20222:08 pmRNSNotice of AGM
20th Apr 202212:19 pmRNSDirector Declaration
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
14th Mar 20227:02 amRNSChief Financial Officer Board Appointment Date
14th Mar 20227:00 amRNSPublication of 2021 Annual Report and Accounts
28th Feb 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSFinal Results
2nd Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSDirectorate Change
7th Jan 20227:00 amRNSFY 2021 Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 202110:01 amRNSDirector/PDMR Shareholding
2nd Dec 20213:07 pmRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSDirectorate Change
1st Dec 202110:19 amRNSAdditional Listing
29th Nov 202110:53 amRNSDirector/PDMR Shareholding
24th Nov 20212:00 pmRNSDirector/PDMR Shareholding
12th Nov 202110:30 amRNSDirector/PDMR Shareholding
8th Nov 202110:49 amRNSDirector/PDMR Shareholding
4th Nov 20217:05 amRNSResults for the nine months to 30 September 2021
29th Oct 202110:02 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.